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Abstract:  We compared absolute values of regional tissue hemoglobin 
saturation (StO2), reproducibility, and dynamic range of four different 
instruments on the forearm of adults. The sensors were repositioned 10 
times on each subject. Dynamic range was estimated by exercise with 
subsequent arterial occlusion. Mean StO2 was 70.1% ± 6.7 with INVOS 
5100, 69.4% ± 5.0 with NIRO 200 NX, 63.4% ± 4.5 with NIRO 300, and 
60.8% ± 3.6 with OxyPrem. The corresponding reproducibility Sw  was 
5.4% (CI 4.4–6.9), 4.4% (CI 3.5–5.2), 4.1% (CI 3.3–4.9), and 2.7% (CI 
2.2–3.2),  respectively.  The  dynamic  ranges  ΔStO2  were 45.0%, 46.8%, 
44.8%, and 27.8%, respectively. In conclusion, the three commercial NIRS 
instruments showed different absolute values, whereas reproducibility and 
dynamic range were quite similar. 
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1. Introduction 
Cerebral tissue oximetry by near-infrared spectroscopy (NIRS) is a growing monitoring 
modality during surgery and intensive care. Accumulating evidence suggest that cerebral 
NIRS could have prognostic value [1,2], however clinical utility remains to be proven. 
Concerns have been raised about the validity and precision of the technology [3,4]. Here we 
introduce a practical method to compare the most important characteristics of tissue oximetry 
and apply it to 3 commercial NIRS instruments and a prototype. 
The preterm infant is born in a state of hemodynamic instability hence reliable absolute 
values are needed. The values of regional tissue hemoglobin saturation (StO2) from different 
cerebral oximeters are correlated [5], but the absolute values differ systematically. Dullenkopf 
et al. found that there was a mean difference of 11.3% ± 5.4 and 13.8 ± 7.9, when the 
pediatric sensor of INVOS 5100 was compared to the adult sensor and the NIRO 300, 
respectively [6]. Furthermore, poor reproducibility is an important concern when applying 
NIRS in a clinical setting [4]. Using NIRO 300, the within-infant standard deviation (Sw) was 
5.2% with repeated cerebral measurements in preterm newborns [7].Using a different 
instrument, Critikon 2020, the Sw was only 1.7% on the neonatal head [8], but this instrument 
also underestimated changes in concentration of hemoglobin [9]. Thus in order to assess a 
instrument for clinical use the absolute StO2 values, reproducibility, and dynamic range need 
to be tested. 
This study presents the first step in a series of studies of NIRS oximeters. While clinical 
research in neonatology is difficult and test of dynamic range impossible other methods of 
testing are needed. Our overall goal is to facilitate the process of collecting good evidence of 
the benefits and harms of cerebral oximetry. Knowledge of the instruments is important. We 
chose three different continuous wave instruments, that have previously been used in neonatal 
studies: INVOS 5100 (Somanetics, Troy, Michigan, USA), NIRO 300 and NIRO 200 NX 
(Hamamatsu Phototonics, Hamamatsu City, Japan) [10–12] and the prototype OxyPrem 
(Biomedical Optic Research Laboratory, Zurich, Switzerland)—a newly developed 
instrument for neonates. 
We propose a simple and practical setup to test and compare the absolute values, 
reproducibility, and dynamic range of StO2  by different instruments. This has to our 
knowledge not been done before. As these instruments use different source-detector 
separations from 2 to 4 cm, we also studied the effect different source-detector separations 
with the NIRO 200 NX. All measurements were done on the forearm of healthy adults. 
2. Methods 
This project was approved by the local Ethics Committee (Journal no. H-1-2010-055) and the 
National Board of Health (Sundhedsstyrelsen) (Journal no. 8313-75). Six subjects participated 
and written informed consent was obtained. 
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measured by the Harpeden caliper. Exclusion criteria were pregnancy and chronic disease. 
The mean StO2 values and reproducibility of measurements under steady state were tested 
with subjects placed in upright position with the lower arm at heart level. The sensors were 
placed at ten appropriate, but slightly different sites on the upper part of the flexor muscles of 
the lower arm (Fig. 1), and ten measurements were done with each instrument before the next 
instrument was applied. After 30 seconds of stabilization a recording of one minute was 
made. The sensors were held in place by hand and great care was taken not to induce pressure 
on the tissue. During the resiting of each instrument the NIRO 200 NX measured 
continuously in order to assess the spontaneous fluctuations in StO2. 
Testing of dynamic range was done inflating a cuff around the upper arm at heart level 
combined with exercise. The sensors of all four instruments were simultaneously placed on 
four discrete positions of the lower arm (Fig. 1). We made sure that light source-light detector 
distance between adjacent instruments was at least 6 cm. All sensors were positioned so that 
the light path was parallel to the longitudinal direction of the muscles below. Sensors were 
fixated with self-adhesive wrap (Coban LP). Then 30 seconds of maximal force was made 
alternating isometric flexion and extension of the wrist against a resistance provided manually 
by SHS, followed by arterial occlusion by cuff inflation to 250 mmHg. The cuff was deflated 
after 90 seconds. This routine was done three times after which the sensors were rotated and 
measurements were repeated. We aimed for the same positions throughout when rotating the 
sensors. The result was 12 dynamic measurements for each instrument on each subject. 
 
Fig. 1. Illustration of sensor positions during resitings (translucent white rectangle) and 
dynamic measurements (four opaque white ovals with position number). S, source. D, detector. 
In a setup similar to the dynamic range study, the distance between the sensor and light 
source was altered so that 3 times 3 measurements were done with distances of 2.2 cm, 3.0 
cm and 4.0 cm, respectively. These measurements were all done on the flexor muscles 
corresponding to position one on Fig. 1. Only NIRO 200 NX was used, because the design 
allowed putting the light source and detector closer than intended by the manufacturer. The 
distance 2.2 cm is not recommended by Hamamatsu. Empirical data suggest that the 
differential path length factor is not constant below distances of 3 cm [13,14]. 
3. NIRS instruments 
The NIRO 300 and 200 NX (Hamamatsu) use spatially resolved spectroscopy. It is based on 
solution of the diffusion approximation for a highly scattering semi-infinite homogeneous 
media. By measuring the decrease in reflected light as a function of distance the effective 
light attenuation coefficient can be estimated. Then by assuming wavelength dependence of 
the reduced scattering coefficient the spectral shape of the absorption coefficient can be 
calculated and tissue saturation estimated [15]. The distance between the two sensors is 0.8 
cm in both instruments. NIRO 200 NX uses LED (735, 810, and 850 nm) while NIRO 300 
uses laser diodes (775, 810, 847,  and 919 nm). In this study we used a source-detector 
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otherwise. 
INVOS 5100 gives a regional tissue oxygenation (SO2). It uses LED (730 and 810 nm). It 
applies two source-detector distances, 3 and 4 cm. The algorithm is not known to the public, 
but supposedly it “subtracts” the short distance signal from the longer distance in order to 
diminish the contribution of the skin and scalp [16]. In this study we used the adult sensor. 
The OxyPrem was designed and constructed in the Biomedical Optic Research Laboratory 
in Zurich, Switzerland. The design is dedicated to preterm brain. It uses two wavelengths, 760 
nm and 870 nm, four sources and two detectors. The pair-wise source-detector separation is 
1.5 and 2.5 cm. The algorithm involves an auto-calibration that benefits from the multiple 
light paths [17]. In this prototype two simultaneous values of StO2 are calculated – one for 
each detector. The mean of the two is presented here. 
We will refer to the regional tissue oxygenation as StO2 irrespective of instrument. 
4. Statistical analysis 
4.1. Reproducibility 
The distribution of the data was explored by Sharpiro-Wilk’s test for normality. The data was 
normally distributed. Overall mean StO2 and standard deviation for each subject and each 
instrument was determined. A univariate ANOVA with StO2 as the dependent and instrument 
as fixed factor and subject as random factor was done, if significant variation was revealed 
pairwise comparisons of the means for each instrument with post hoc Tukey HSD test would 
be done. Reproducibility for each instrument was determined by one-way ANOVA with 
subject as the factor. The within-subject standard deviation, Sw, was then estimated from the 
square root of the residual mean square. The 95% confidence interval was calculated as 
suggested by Bland and Altman [18]. The within-subject standard deviations for each 
instrument were pair-wise compared with the variance ratio test (F-test). The Bonferroni 
method was applied due to multiple testing. For spontaneous variation in StO2 ten randomly 
chosen, not overlapping, one minute timeframes from the continuous NIRO 200 NX reading 
would be analyzed. 
4.2. Dynamic range 
The dynamic range was calculated as the difference between the pre-exercise steady state 
oxygenation and the deoxygenated steady state. In a Matlab® (Mathworks) script a period of 
10 seconds just before exercise would be chosen by visual assessment. The script would then 
calculate the mean StO2 of those 10 seconds and for another10 seconds exactly 80 seconds 
afterwards, which would typically, be at the lowest StO2 levels. This method was chosen 
because the StO2 would quite often not find a steady state at the lowest values of StO2, but be 
sloping slightly downwards or upwards. 
The StO2 was not normally distributed for subject, position, or instrument. The median 
ΔStO2  was calculated for each instrument and the nonparametric independent samples 
Kruskal-Wallis  test  was  applied  with  ΔStO2  as the dependent and instrument as the 
independent factor. If showing significant variation post-hoc pairwise comparisons were done 
by the SPSS nonparametric test and p-values adjusted according to the Bonferroni method. 
Similar statistics were applied to the study of changing source-detector separations. 
All statistics were calculated in SPSS 18.0; p < 0.05 is considered significant. 
5. Results 
5.1. Population 
Six subjects, five men and one woman participated. They had a double skinfold mean of 4.1 
mm and were from 19 to 30 years of age. The study of source-detector separation was done 
with another 6 male subjects, age range 30–59 years, with double skinfold mean of 3.9 mm. 
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The mean StO2 for each instrument of the ten one minute measurements in the six subjects is 
shown in Table 1. INVOS 5100 had the highest mean StO2 of 70.1 ± 6.7%, OxyPrem the 
lowest StO2 of 60.8 ± 3.6% (Fig. 2). The univariate ANOVA showed significant difference 
between means of instruments. In pairwise comparison significant difference was found 
between all instruments (p < 0.00001), except NIRO 200 NX and INVOS 5100. The mean 
StO2 averaging all four instruments on each subject (n = 40) varied significantly (p < 0.003), 
range 61.8 ± 6.0% to 68.9 ± 6.3%. 
Table 1. Mean regional tissue oxygenation StO2 of each instrument
a 
Instrument  INVOS 5100  NIRO 200 NX  NIRO 300  OxyPrem 
StO2 ± sd (%)  70.2 ± 6.7  69.4 ± 5.0  63.4 ± 4.5*  60.8 ± 3.6* 
aThe mean of ten measurements in each of six subjects: n = 60. 
*Significantly different from the other three devices (p < 0.00001) 
5.3. Reproducibility 
The within-subject standard deviation for each instrument is presented in Table 2. Ranging 
from 5.4% (CI 4.4–6.9) in INVOS 5100 to 2.7% (CI 2.2–3.2) in OxyPrem. In pairwise 
comparison after correction for multiple testing the two NIROs and the INVOS had similar 
Sw, while OxyPrem had a significantly lower Sw than the other three instruments (p < 0.01). 
Of the total variance Sw accounted for 61%, 82%, 71%, and 53% with INVOS, NIRO 200 
NX, NIRO 300, and OxyPrem, respectively. The spontaneous fluctuations represented by Sw 
of randomly selected 1-minute periods measured by NIRO 200 NX was 1.5% (CI 1.2–1.8) 
5.4. Dynamic Range 
The  median  ΔStO2  of INVOS 5100, NIRO 200 NX, and NIRO 300 was 45.0%, 46.8%, 
44.8%, respectively. The median ΔStO2 of the OxyPrem was 27.8%, which was significantly 
lower than the other three devices (p < 0.001) (Table 2)(Fig. 2). A typical tracing of StO2 of 
the NIRO 200 NX is given in Fig. 3. There was missing data from all 4 devices—ranging 
from 6 measurements with NIRO 300 to 1 measurement with INVOS 5100. The ΔStO2 was 
dependent on sensor position. Position one and two on Fig. 1 gave overall ΔStO2 mean values 
of 49.4% (CI 44.9–54.0) and 49.0% (CI 45.6–52.3), respectively, while position three and 
four gave mean values of 26.3% (CI 22.9–29.6) and 33.1% (CI 29.6–36.7). 
5.5. Source-detector separation 
The median ΔStO2 was 68.9% (quartile range (IQR) 9.6) with 2.2 cm, 63.1% (IQR 8.5) with 
3.0 cm, and 45.9% (IQR 6.6) with 4 cm source-detector separation, respectively. The median 
ΔStO2 varied significantly across the different source-detector separations (p < 0.001). It was 
not possible to measure StO2 during de-oxygenation with a distance of 4 cm in three of the 
subjects due to “signal underflow.” 
Table 2. Reproducibility Sw and dynamic range ΔStO2 for each instrument
a 
Instrument  Sw (%)  SE (%)  95% CI (%)  ΔStO2 (%)  IQR (%) 
INVOS 5100  5.4  0.5  4.4–6.5  45.0  29.7 
NIRO 200 NX  4.4  0.4  3.5–5.2  46.8  29.4 
NIRO 300  4.1  0.4  3.3–4.9  44.8  40.1 
OxyPrem  2.7*  0.3  2.2–3.2  27.8**  10.3 
aSw, Ten resitings (m) in six subjects (n): mn = 60. SE, Standard error. ΔStO2: Three repeated measurements on four 
different sites in six subjects: n = 72. 
*Significantly different from the other three instruments (p < 0.01). 
**Significantly different from the other three instruments (p < 0.001). 
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Fig. 2. For each instrument: On the left side the mean StO2 with 95% CI (box) and 95% 
reference range. On the right side dynamic range with mean StO2 pre- and post-exercise with 
95% CI (boxes) 
 
Fig. 3. A tracing of StO2 with the NIRO 200 NX during exercise and arterial occlusion 
6. Discussion 
6.1. Statement of principal findings 
We found that the steady state mean StO2 was similar between NIRO 200 NX and INVOS 
5100, while the mean StO2 of NIRO 300 was significant less. The NIRO 200 NX, NIRO 300, 
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OxyPrem had better reproducibility, the lowest steady state mean, and a dynamic range of 
only 60% of the other instruments. 
6.2. Appraisal of methods 
We used a simple, feasible setup to compare NIRS instruments. Numerous comparisons 
between different instruments have been reported [5,6,19–22]. The novel aspect of our 
approach is that we combine repeated resitings and dynamic measurements and estimate the 
reproducibility of several instruments in same setting. We propose that forearm muscle can 
serve as a model for the brain of the preterm infants, because the light has to travel through 
multiple layers offering comparable optical heterogeneity. We chose lean subjects to mimic 
the thin scalp and skull in preterm infants. It is likely that both during fluctuations in muscle 
and brain oxygenation, the oxygenation of the overlying skin and bone will vary less. 
Therefore the challenge of discriminating between superficial and more profound tissue is the 
same. Oxygen-hemoglobin saturation can be controlled more precisely in an in-vitro 
phantom, but it is difficult to create the optical heterogeneity of tissue, particular at the small 
scale, such as caused by hair, pigmentation, and blood vessels. Furthermore, instruments 
using different wavelengths will respond differently to a phantom using non-hemoglobin 
chromophores. We were able to achieve minimum values of StO2 below 10% by combining 
maximal exercise and arterial occlusion fast enough to allow multiple measurements. This 
provides a good signal to noise ratio and thus presents an effective setup for comparisons 
between different instruments. A similar dynamic range can only be achieved in-vivo for the 
brain by the use of animal models. Animal models are anatomically different and they are less 
easily available. For comparison, using the human adult forearm entails no risk and minimal 
inconvenience. 
Some limitations of our approach deserve notice. 1) It is uncertain how absolute values on 
the arm agree with values on the head. Important differences in geometry, optical properties, 
and water content between arm and brain are likely to be processed differently by different 
instruments with different algorithms. 2) The testing of dynamic range had an inherent source 
of error. After the first de-oxygenation the subsequent hyper-perfusion would result in larger 
ΔStO2 during the next 11 measurements. We compensated for this by varying the order of the 
instruments in each subject. 3) It is possible that the instruments probe bone especially at 
position 3 and 4 on Fig. 1. How this influences the dynamic measurements is uncertain, but it 
could introduce considerably bias depending on algorithm and source-detector distance. 4) 
The ΔStO2 was highly dependent on sensor position, i.e., ranging from a mean ΔStO2 of 
49.4% to 26.3%. 5) The ΔStO2 would occasionally differ more than 40 percentage points 
between repeats. This can probably be explained by minor displacement of the sensors during 
the exercise. 
Despite these limitations it seems reasonable that a better reproducibility on the forearm 
translates to a better reproducibility on the head. And if the OxyPrem is significantly less 
sensitive to changes in oxygenation on the lower arm it is likely that this translates into less 
sensitivity to changes in the brain. Thus we suggest that clinical relevant information can be 
obtained from this test model. 
6.3. Comparison with previous work 
The mean resting StO2 in this study compares variably with previous studies. Komiyama et al. 
found a mean of 65.6 ± 5.6% (n = 18) with NIRO 300 in the flexor digitorum muscle on the 
lower arm [23].This is similar to our results with NIRO 300, i.e. mean difference (MD) 2.2 
(Confidence interval (CI) −0.4–4.8). Rodriguez et al. used the INVOS 5100 on the medial 
forearm and measured a mean StO2 of 67.3 ± 7.1% (n = 50). Compared with our result with 
the INVOS there is a significant difference with a MD of 2.9 (CI 0.2–5.6). Shiroishi et al. 
used the NIRO 200 on the flexor muscles of the forearm and found a resting StO2 of 61.4 ± 
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8.0 CI 4.6 −11.4), but similar to our results with the NIRO 300 (MD 2.0 CI −1.1–5.1). A 
possible explanation for this varied agreement with literature could be different populations. 
For example the thickness of the skin, that may influence the mean values, is not documented 
in most of the studies [25]. 
As previously reported, our study confirms, that instruments and sensors differ in StO2 
values [6,20]. The difference in source-detector separation could be a possible explanation. It 
is still debated to what extent the more superficial tissues influence the measurement, e.g. 
Germon et al found a significant effect of varying the extra cranial perfusion [26] while others 
report negligible contributions from the extra cranial tissues [27,28]. The skin is believed to 
have a lower oxygen extraction than muscle. In spatially resolved spectroscopy the depth of 
measurement is correlated with the source-detector separation. The wider the distance is, the 
deeper the measurement. However all our study subjects had very thin subcutaneous layer 
with double skinfolds less than 5 mm, which obviously diminishes the skin’s contribution to 
the signal. The possible probing of bone are less likely during these measurements since the 
mean values were collected in the area of resitings in Fig. 1. Thus it seems reasonable to 
assume that the StO2 differences between the different instruments are primarily caused by 
other factors, most likely the different algorithms, although surprisingly there was significant 
difference between the two NIROs. NIRO 200 NX with the shortest source-detector 
separation giving the highest mean value. 
To our knowledge the reproducibility of NIRS StO2 measurements has not been evaluated 
on the lower arm before. The OxyPrem showed lowest Sw, which contributed least to the total 
variance. However the estimates of between subject variance are imprecise due to the limited 
sample size. .In neonates a very recent study with an earlier version of the OxyPrem found a 
similar Sw of 2.76% [29]. In addition Sorensen et al. found a Sw of 5.2% (CI 4.7–5.7) with 
NIRO 300 [7]. Comparable to this we measured a Sw of 4,1% (CI 3.3–4.9) using NIRO 300. 
Similarly Dullenkopf et al. found that measurements with NIRO 300 on the same location of 
the scalp by two identical sensors 1 minute apart showed limits of agreement from −17.8% to 
17.6% in a mixed population of neonates and pediatric patients corresponding to a Sw of 6.4% 
(CI 4.4–8.4), again comparable to our results [30,31]. In a recent study by Pocivalnik et al. the 
NIRO 300 was compared with INVOS 5100 with 5 repeated measurement on the head of 
neonates, predominately preterms. They found comparable reproducibility, but a significantly 
higher mean StO2 with the INVOS neonatal sensor 84.1% ± 6.4 vs. 73.1% ± 6.9 with NIRO 
300 [32]. Higher values of StO2 when using the neonatal INVOS sensor has previously been 
shown [6]. Pocivalnik et al. estimated the reproducibility by the mean standard deviation, 
which is not comparable to the within-subject standard deviation. In conclusion our results 
compares well with studies of reproducibility of cerebral StO2 in neonates. 
Does the lack of agreement and reproducibility represent optical heterogeneity, 
physiological fluctuations, and/or regional differences in oxygenation? Watzman et al. found 
that the arterial-venous ratio differed between subjects ranging from 0:100 to 40:60 [33]. 
However the study did not take the possible lack of precision of the used prototype NIRS 
oximeter into consideration and the variation could be the result of optical heterogeneity. 
Wong et al. suggests that there could be a within-subject variation in arterial-venous ratio. In 
lambs, they found that during hypoxaemia the arteries contribute more to the signal indicating 
possible arterial vasodilatation [34]. This makes sense, but is based on the assumption that the 
accuracy of NIRS is independent of level of oxygenation. It, however, cannot explain the 
steady state imprecision/variation we found. Moreover studies where sensors were 
repositioned at different sites [7] and studies where they were repositioned at the same site 
[30] have shown similar reproducibility. During our reproducibility study we had a 
continuous StO2  measurement with the NIRO 200 NX. Ten randomly chosen 1-minute 
periods representing pseudo-resisting and thereby quantifying spontaneous fluctuations in 
oxygenation gave a Sw of 1.5% (CI 1.2–1.8). This indicate that most of the variation, that we 
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reproducibility of cerebral oximetry is primarily caused by optical heterogeneity. 
Our test of dynamic range is a measure of sensitivity to changes in tissue oxygenation. To 
our knowledge this way of comparing instruments has not been used before. The changes in 
oxygenation achieved compare reasonably well with other dynamic muscle studies using 
NIRS oximeters [35,36]. The three commercially available instruments showed similar 
performance, indicating equivalent sensitivity to changes in muscle oxygenation. The 
OxyPrem was far less sensitive to oxygenation changes and StO2 rarely went below 30%. We 
altered the source-detector separation on the NIRO 200 NX to test whether the  shorter 
distance on the OxyPrem could explain our results. Our data does not support this hypothesis. 
Our results indicate that NIRO 300, NIRO 200 NX, and INVOS 5100 are equally suited 
for simple dynamic muscle measurements, if only changes in StO2 are needed. The steady 
state reproducibility and absolute StO2 values are not that important in studies of muscle 
physiology, but matters highly in clinical care. The OxyPrem did show better reproducibility, 
but perhaps at the expense of good sensitivity. However the intention of testing cerebral NIRS 
oximeters for neonatal clinical care on the adult arm should be validated in a suitable animal 
model. 
6.4. Validity 
The cerebral StO2 correlates with venous jugular bulb saturation, but the agreement is poor 
with a mean bias about –4% and limits of agreement from −20% to +12% [37–39]. These 
studies are done without analysis of the within-subject agreement. It could be that the lack of 
agreement is primarily caused by optical heterogeneity. Perfect agreement is however 
unlikely, since jugular bulb saturation is flow-weighted, while cerebral oximetry is volume 
weighted. During states of microcirculatory heterogeneity, like sepsis, a lot of vessels in the 
brain will not be perfused will others will be hyperperfused. This will theoretically affect 
jugular bulb saturation less than NIRS oximetry that also will measure the deoxygenated pool 
of blood in the underperfused vessels. It remains to be determined what modality is the best 
predictor of cerebral outcome, but NIRS has the great advantage of non-invasiveness. 
6.5. Clinical implications 
Two problems with cerebral oximetry are highlighted by our results: the difference in 
absolute StO2  values between instruments and the lack of reproducibility. The varying 
absolute values  between instruments causes the determination of normal ranges and 
thresholds for hypoxic-ischemic brain injury to be problematic. From studies in piglets StO2 
levels below 35-40% has been damaging to the brain [40,41], but since different non-
commercial instruments are used in these studies, it is not simple to translate this into clinical 
care, where other instruments are available. During surgery it has become standard to use 
changes from pre-operative StO2, but in neonatal care where infants are born in a state of 
cardio-pulmonary instability, no such set point exist. The reliability of the absolute values is 
therefore important. The OxyPrem data shows that such reproducibility can be achieved. 
However since the OxyPrem was less sensitive to changes in oxygenation the ability to 
distinguish between deleterious low and safe normal StO2 might not be better than with the 
commercial instruments. Estimating the signal/noise ratio (range/Sw) gave 8.2, 10.8, 10.9 and 
10.2 with INVOS 5100, NIRO 200 NX, NIRO 300 and OxyPrem, respectively. This suggests, 
with the caveat that this is a less than perfect model for the neonatal brain, that the 
instruments are equally suited for clinical purposes. 
Optical heterogeneity is probably the primary cause of the poor reproducibility of the 
commercial instruments and a possible solution could be to use 2 channels at a time and work 
with the mean of these. The alternative, to do repositioning manually is too cumbersome 
outside a trial setting. The clinical potential of cerebral NIRS is still unclear, but further 
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maintaining good sensitivity seems paramount. 
6.6. Conclusion 
We compared three commercial NIRS instruments on the forearm of adults and found that the 
absolute values of StO2 differ between instruments, while reproducibility and dynamic range 
were similar. The results with the prototype OxyPrem suggest that the reproducibility of 
cerebral NIRS can be improved. 
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